GENEVA, Feb. 18 -- DAEWOONG PHARMACEUTICAL CO., LTD. (35-14, Jeyakgongdan 4-gil, Hyangnam-eup,Hwaseong-si,Gyeonggi-do 18623), 주식회사 대웅제약 (경기도화성시향남읍 제약공단4길 35-14) filed a patent application (PCT/KR2025/011836) for "NOVEL QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME" on Aug 06, 2025. With publication no. WO/2026/035034, the details related to the patent application was published on Feb 12, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (W...